ArticleCellular & molecular biology letters2024

Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.

Weisong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.